SuperworthVaxcyte shares outstanding PCVX
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 144.5M
- On a year earlier
- +6.2%
- more shares
Vaxcyte had 144.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 6.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 136.4M | +1% |
| FY2024 | 135.1M | +32% |
| FY2023 | 102.5M | +30% |
| FY2022 | 78.9M | +49% |
| FY2021 | 52.8M | +4% |
| FY2020 | 51M | +1185% |
| FY2019 | 4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 144.5M | +6% | |
| Q1 FY26 | 139.5M | +3% | |
| Q4 FY25 | 136.4M | +1% | |
| Q3 FY25 | 136.2M | +10% | |
| Q2 FY25 | 136M | +16% | |
| Q1 FY25 | 135.7M | +21% | |
| Q4 FY24 | 135.1M | +32% | |
| Q3 FY24 | 123.7M | +22% | |
| Q2 FY24 | 117.3M | +20% | |
| Q1 FY24 | 111.7M | +30% | |
| Q4 FY23 | 102.5M | +30% | |
| Q3 FY23 | 101.7M | +64% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Vaxcyte
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.